echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Qilu won 1 billion injections

    Qilu won 1 billion injections

    • Last Update: 2022-01-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    A few days ago, the official website of the State Food and Drug Administration showed that Qilu Pharmaceutical's recombinant human follicle stimulating hormone for injection was approved for marketing.


    Sales of terminal recombinant human follicle stimulating hormone injections in Chinese public medical institutions in recent years (unit: 100 million yuan)

    Source: Mi Nei.


    Recombinant human follicle stimulating hormone for injection is used to treat infertility


    Qilu Pharmaceutical said that the recombinant human follicle stimulating hormone for injection is a blockbuster product that has been researched for 11 years.


    Source: Meinenet MED2.


    Since the beginning of this year, Qilu Pharmaceutical has approved 7 injections, among which, Ceftazidime Avibactam Sodium for injection won the first imitation in China


    Source: official website of the State Food and Drug Administration, Mi Nei.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.